Hansa Biopharma Logo

Hansa Biopharma

HNSA | ST

Overview

Corporate Details

ISIN(s):
SE0002148817 (+1 more)
LEI:
549300LLEO25ZJJ3NT91
Country:
Sweden
Address:
Box 785, 220 07 Lund
Sector:
Health Care
Industry:
Biotechnology

Description

Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company. Our vision is a world where all patients with rare immunologic diseases can lead long and healthy lives. But we often see that people with rare diseases are relegated to the impossible and left to fend for themselves. That’s not the way forward. We see all patients as equal individuals with individual needs. A point of view that gives us a unique ability to deliver the most inclusive care to everyone. For us the mission is clear – we want to develop lifesaving and life altering therapies to those who need them the most. And ultimately, we can – and will – eliminate rare diseases, one patient at a time. So how do we aim to achieve our goal? • We partner with global scientific, medical, and patient communities to identify the most urgent needs • We work relentlessly to meet the needs and create lifesaving treatments • Our lead program enables kidney transplantation in difficult-to-transplant patients

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-30 07:00
Regulatory News Service
Hansa Biopharma: Ökning av antalet aktier och röster
Swedish 208.0 KB
2025-06-30 07:00
Regulatory News Service
Hansa Biopharma: Increase in number of shares and votes
English 204.6 KB
2025-06-25 16:00
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma i Hansa Biopharma AB (publ)
Swedish 231.8 KB
2025-06-25 16:00
Declaration of Voting Results & Voting Rights Announcements
Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
English 247.2 KB
2025-06-25 11:25
Declaration of Voting Results & Voting Rights Announcements
Swedish 11.6 KB
2025-06-19 01:21
Inside Information Statement
Hansa Biopharma has carried out a directed cash share issue of approx. mSEK 232…
English 327.9 KB
2025-06-19 01:21
Inside Information Statement
Hansa Biopharma har genomfört en riktad kontantemission om ca 232 miljoner kron…
Swedish 324.2 KB
2025-06-18 17:35
Inside Information Statement
Hansa Biopharma avser att genomföra riktad nyemission om cirka 10 miljoner akti…
Swedish 332.6 KB
2025-06-18 17:35
Inside Information Statement
Hansa Biopharma intends to carry out directed share issue of approximately 10 m…
English 326.2 KB
2025-05-26 18:40
Regulatory News Service
Hansa Biopharma plans restructuring to optimize resource allocation and improve…
English 220.5 KB
2025-05-26 18:40
Regulatory News Service
Hansa Biopharma planerar omstrukturering för att optimera resursfördelning och …
Swedish 204.8 KB
2025-05-26 07:00
Proxy Solicitation & Information Statements
Notice to Annual General Meeting in Hansa Biopharma AB (publ)
English 206.6 KB
2025-05-26 07:00
General Meeting Notice
Kallelse till årsstämma i Hansa Biopharma AB (publ)
Swedish 461.9 KB
2025-04-24 08:00
Quarterly Report
Swedish 1.8 MB
2025-04-24 08:00
Earnings Release
English 1.6 MB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-06-17 Anne Säfström Lanner Other Sell 10,487 443,285.49 SEK
2024-06-17 Sören Tulstrup Other Sell 9,199 388,841.73 SEK
2024-06-17 Sören Tulstrup Other Buy 35,200 N/A
2022-07-19 Peter Nicklin Other Buy 14,500 1,032,192.68 SEK
2022-06-17 Christian Kjellman Other Buy 6,915 345,680.85 SEK
2022-06-17 Donato Spota Other Sell 4,638 231,853.62 SEK
2022-06-17 Christian Kjellman Other Sell 4,002 200,059.98 SEK
2022-06-17 Sören Tulstrup Other Sell 3,925 196,210.75 SEK
2022-06-17 Sören Tulstrup Other Buy 3,925 196,210.75 SEK
2022-06-17 Anne Säfström Lanner Other Sell 2,685 134,223.15 SEK

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC